Injective vs Linea
Compare Injective and Linea on TVL, fees, revenue and activity to understand how these projects stack up.
$14.27M
Injective is a Cosmos‑SDK Layer‑1 with on‑chain order books, zero‑gas trading and a frequent batch auction that mitigates MEV. Its built‑in Ethereum bridge lets users bring ERC‑20s without custodial risk, and the WasmX module supports CosmWasm smart contracts. INJ holders can stake or participate in governance that controls upgrades like the 2024 Volan hard fork which added liquid staking.
View Full Page$23.37M
Linea is Consensys’ zkEVM rollup offering bytecode‑level equivalence with Ethereum and zero‑knowledge proofs generated by the Scroll‑inspired ‘Plonky3’ prover. The network is integrated directly into MetaMask, and sequencer fees can be paid in any ERC‑20 via a paymaster contract. Linea has secured over 200 million TVL and finalises proofs on mainnet every 10 minutes.
View Full PageKey Metrics Comparison
Injective
TVL$14.27M
24h Volume$5.03M
24h Fees$488
24h Revenue$151
30d Fees$33.7K
30d Revenue$8.7K
7d TVL Change+20.34%
Dominance0.01%
Linea
TVL$23.37M
24h Volume$321.7K
24h Fees$1.3K
24h Revenue$593
30d Fees$63.5K
30d Revenue$39.9K
7d TVL Change-3.30%
Dominance0.01%
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
TVL Share
Share of combined TVL
Injective
37.9%Linea
62.1%Volume Share
Share of combined 24h volume
Injective
94.0%Linea
6.0%Fees Share
Share of combined 24h fees
Injective
28.0%Linea
72.0%Revenue Share
Share of combined 24h revenue
Injective
20.3%Linea
79.7%7d TVL Performance
TVL change over last 7 days
Injective
20.34%Linea
-3.30%Dominance
Market dominance by TVL
Injective
0.0%Linea
0.0%TVL Comparison
Injective
Linea